UOC
PRTK

UBS O'Connor’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

UBS O'Connor’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-40,000
Closed -$556K – 474
2016
Q2 		$556K Buy
+40,000
New +$556K 0.01% 335